Heather Moore
Advertisement
Articles by Heather Moore
15 Updated Expert Consensus Recommendations for Managing Hyperglycemia and Rash in Patients With PIK3CA-Mutated, Hormone Receptor–Positive (HR+), Human Epidermal Growth Factor Receptor 2–Negative (HER2–) Advanced Breast Cancer Treated With Alpelisib
ByEmily J. Gallagher,Heather Moore,Mario E. Lacouture, MD,Susan F. Dent,Azeez Farooki, MD,Marcus D. Goncalves,Claudine Isaacs, MD,Abigail Johnston,Dejan Juric,Zoe Quandt,Laura Spring,Brian Berman,Melanie Decker,Gabriel N. Hortobagyi, MD, FACP,Benjamin H. Kaffenberger,Bernice Y. Kwong,Timothy Pluard,Ruta Rao, MD,Lee Schwartzberg, MD, FACP,Michael S. Broder
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Nab-Sirolimus Regimens Show Promise in HR+/HER2-Negative Breast Cancer
2
FDA Approves Narsoplimab for HSCT-Associated Thrombotic Microangiopathy
3
Ivosidenib Combo Shows Preliminary Activity in IDH1-Mutated AML
4
Bioimpedance Spectroscopy is Allowing for Lymphedema Reduction in Breast Cancer
5